Morepen Laboratories is a brand-new company record, and its full research profile isn't ready yet.
morepen.comCrawled Oct 25, 2026
Cardia finished formulations for diabetes and heart health, made at Morepen's WHO GMP formulation facilities.
Custom development and manufacturing from key intermediates and API process chemistry through scale-up and commercial supply.
Formulation development, analytical work, stability and dossier support for partners, alongside finished-dose manufacturing.
Medical devices, prescription medicines and Dr. Morepen OTC brands, including glucose monitors, Cardia, Medicus and Burnol.
Exchange filings, shareholder notices and newspaper publications from Morepen Laboratories.
Investor updates and exchange announcements from Morepen Laboratories, listed on NSE and BSE.
Open roles at Morepen Laboratories across manufacturing, research, quality, commercial and corporate teams in India.
614 KL installed API and CDMO reactor capacity across Morepen's manufacturing network in Himachal Pradesh.
The company develops non-infringing, cost-effective processes for generic drug manufacturing, recognized by government authorities.
Investor updates, press releases and media for Morepen Labs, listed on NSE and BSE. Presentations, results and annual reports.
Four decades in Baddi: 10 manufacturing plants, recognised R&D, and Dr. Morepen and Gubb brands trusted by over 100 million consumers.
Contact Morepen Laboratories for API, CDMO, formulation and healthcare enquiries. Offices in Gurugram, Himachal Pradesh and New Jersey.
Customer support form for Morepen Laboratories and Dr. Morepen product enquiries.
Morepen combines more than four decades of API manufacturing experience with an expanding CDMO platform, drug-product development capabilities and healthcare businesses. The focus is increasingly on long-duration global partnerships, regulated-market execution and science-led growth.
How Morepen Laboratories handles enquiries, career applications and adverse-event reports submitted through this website.
Code of conduct for directors and senior management of Morepen Laboratories Limited.
Disclaimer for Morepen Laboratories investor materials, including forward-looking statements.
Disclaimer for Morepen Laboratories qualified institutions placement materials. Not an offer or solicitation.
Disclaimer for the Morepen Laboratories website. Content is corporate information, not medical advice or a securities offer.